Prostate cancer screening guidelines have been evolving for more than a decade, but new research suggests that recommendations against routine prostate cancer testing may have come at a steep price -- more men getting diagnosed with advanced prostate cancers.
The study found that rates of advanced prostate cancers rose by about 5% per year through 2016.
New treatments for melanoma have dramatically reduced deaths from this often fatal skin cancer.
Leaders of a new study report that the death rate from aggressive melanoma that spread to other organs plummeted 18% between 2013 and 2016, after jumping 7.5% between 1986 and 2013. The figures apply to white Americans, the group that accounts for nearly all cases of melanoma in th...
People with a history of certain cancers have more than double the risk for the heart rhythm disorder atrial fibrillation, a new study says.
A-fib is a common disorder that can lead to palpitations, dizziness and fatigue. Untreated, it can cause blood clots, stroke and heart failure, and people with a-fib have five times the risk of stroke than other people.
Exercise benefits prostate cancer patients who undergo hormone-reducing therapy, a small study suggests.
The treatment -- called androgen suppression therapy or androgen deprivation therapy (ADT) -- uses drugs or surgery to reduce the level of androgen hormones, which prostate cancer cells typically require to multiply.
"The problem is ADT has several side effects, including...
Adding MRI to a standard tissue biopsy appears to enhance the accuracy of a prostate cancer diagnosis, new research finds.
The study, led by researchers at the U.S. National Cancer Institute (NCI), found that combining the two methods cut the rate of "underdiagnosis" by more than half, compared to use of either MRI or biopsy alone.
Drugs that many men with prostate cancer might already be taking -- cholesterol-lowering statins -- may help extend their survival if they have a "high-risk" form of the disease, new research suggests.
High-risk patients include men with high blood levels of prostate specific antigen (PSA) and a "Gleason score" of 8 or more. Gleason scores are a calculation used to gauge prognosis in...
High levels of the sex hormone testosterone may trigger different health problems in men and women, a new study reveals.
In women, testosterone may increase the risk for type 2 diabetes, while in men it lowers that risk. But high levels of testosterone increase the risk for breast and endometrial cancer in women and prostate cancer in men, the researchers reported.
In another step toward using artificial intelligence in medicine, a new study shows that computers can be trained to match human experts in judging the severity of prostate tumors.
Researchers found that their artificial intelligence system was "near perfect" in determining whether prostate tissue contained cancer cells. And it was on par with 23 "world-leading" pathologists in judgin...
A 29% drop in U.S. cancer deaths between 1991 and 2017 was driven by declines in deaths from four major cancers -- lung, colon, breast and prostate, according to the latest American Cancer Society (ACS) annual report.
Cancer deaths in the United States fell 2.2% between 2016 and 2017, the largest-ever single-year decrease.
Here's some worrisome news for folks who manage to survive a heart attack: New research suggests they might be far more vulnerable to developing cancer down the road.
People who suffered a heart health scare -- a heart attack, heart failure or a dangerously erratic heart rhythm -- had a more than sevenfold increased risk for subsequently developing cancer, compared to those with healt...
A drug that targets faulty gene repair may buy more time for some men with advanced prostate cancer, a new clinical trial finds.
Experts called the study "landmark," because it zeroed in on men with particular gene mutations that can be targeted with newer drug therapies. It's an approach that is already used in treating breast, ovarian and lung cancers.
In the largest investigation of its kind, researchers conclude that subjecting prostate cancer patients to radiation therapy immediately after surgery doesn't give them an advantage in staying cancer-free.
The finding stems from a review of four studies that together tracked outcomes for more than 3,500 prostate cancer patients from multiple countries.
Running contrary to current guidelines, new research suggests that use of hormone-suppressing treatment over the long term may not help some men battling recurrent prostate cancer, and may even cause harm.
In fact, the study found that long-term hormone therapy was tied to a raised risk of death from other causes for some patients who received it.
In what might be a major breakthrough, researchers report that high doses of radiation dramatically prolonged survival in men battling an advanced and aggressive form of prostate cancer.
This particular type of cancer occurs when tumors resurface and spread to a number of areas beyond the prostate among patients who were in remission following radiation, surgery or chemotherapy. Gene...
Prostate cancer is the second most common cancer in American men, so it's important to know the risk factors and warning signs, an expert says.
The American Cancer Society estimates there will be nearly 175,000 new prostate cancer cases in the United States this year and over 31,000 deaths. One in nine men will be diagnosed with prostate cancer in their lifetime.
Since the turn of the century, American obesity rates have skyrocketed. And now a new study indicates that as the nation's waistlines expand, cancers long linked to obesity are striking the middle-aged more than ever before.
The finding follows a review of data on more than 6 million white, black and Hispanic cancer patients diagnosed between 2000 and 2016.
When men have both advanced prostate cancer and heart disease, treatment may pose a dilemma: Newer hormonal therapies that can slow the cancer down might also be risky for their hearts, a new study finds.
Once prostate cancer spreads beyond the gland, one of the mainstays of treatment is hormone therapy. The aim is to prevent androgens ("male" hormones such as testosterone) from feedi...
Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment. But those so-called antiandrogens also might put them at risk for a deadly heart condition, according to new research.
In a study published Monday in the American Heart Association journal Circulation, researchers looked at how several testosterone-blocking drugs affect the h...
A man who learns he has prostate cancer faces a difficult choice: whether to immediately treat the cancer despite potential side effects or wait and see if it's a slow-growing tumor that never needs treatment.
Men may soon have help making that decision.
Researchers from the United Kingdom report that they've created a urine test that can predict the aggressiveness of a pr...
A possible link between World Trade Center dust and prostate cancer in first responders has been found by researchers.
Exposure to dust at the New York City site after the Sept. 11, 2001, terrorist attacks triggered chronic inflammation in the responders' prostates, which may have contributed to their cancer, according to the Mount Sinai Health researchers.
"Watchful waiting" is on the rise overall among U.S. men with low-risk prostate cancer, but black men remain less likely to opt for it, a new study finds.
For the study, researchers examined 2010-2015 data on more than 50,000 low-risk prostate cancer patients in the United States. The investigators found that black men were 16% less likely than other men to decide on watchful wai...
Some people with sleep apnea have an increased risk of cancer, and the odds may be higher for women than men, researchers say.
"Recent studies have shown that low blood oxygen levels during the night and disrupted sleep, which are both common in [obstructive sleep apnea], may play an important role in the biology of different types of cancers," said study leader Athanasia Pataka.
Treating men with low-risk prostate cancer with just one high dose of radiation may be safe and effective, British researchers report.
Therapy for prostate cancer typically involves low-dose radiation given over several days or weeks. Conversely, high-dose radiation is given once through a set of tiny tubes inserted directly into the tumor.
Rates of prostate cancer cases and deaths have declined or stabilized in many countries. And the United States had the largest recent decrease in disease incidence, a new study says.
"Previous studies have indicated significant variation in prostate cancer rates, due to factors including detection practices, availability of treatment, and genetic factors," said study author MaryBeth F...
Hormonal treatment can help control prostate cancer but may increase a man's risk of depression, a new study by Danish researchers suggests.
Male hormones, such as testosterone, are known to fuel the growth of prostate tumors. So doctors use drugs to reduce hormone production. But that can bring on tough side effects, such as incontinence or impotence.
A new report from the American Cancer Society brings good news and bad news for black Americans.
The number of black lives lost to cancer is falling, the report finds, and at a faster rate than observed among whites. That's helping to close a decades-long "race gap" in cancer deaths between blacks and whites.
"Seeing the substantial progress made over the past several decade...
Finasteride, best known as the enlarged-prostate medicine Proscar, is a safe, effective way to reduce the risk of prostate cancer, according to long-term findings from the Prostate Cancer Prevention Trial (PCPT).
The trial was funded by the U.S. National Cancer Institute and enrolled nearly 19,000 men between 1993 and 1997.
Initially it found that finasteride -- a hormone-bl...